2
The first uses of electroanalgesia were recorded by Aristotle, Pliny and Plutarch, who reported application of electrical fish to pain sites.

3
BACKGROUND Neuropathy is a common complication of diabetes. Painful neuropathy (PN) is gradually being recognized as a significant cause of morbidity in children with diabetes. (Abad F et al, 2002; Karsidag S et al, 2004; Hamilton J et al,2004) Many drugs are available to manage PN, but all have limited application in paediatric population.

5
PRESENT STATUS Few reports are available, however, on the use of TENS in diabetic painful neuropathy (Kalra et al 2006, Alvaro M et al, 1999) No reports are available on effect of TENS in paediatric diabetes.

20
Results Pain scores reduced significantly in both groups, but much more so in the TENS group (from 4.60 ± 0.54 to 2.40 ± 0.54) than the sham electrodes + oxcarbamazepine group (from 4.40 ± 0.54 to 3.60 ± 0.54). A significant change was seen in health distress and disease intrusion scores in the TENS group

24
DOSE The dose of TENS used varied from 5.5 to 9.0 Hz on the initial day to 3.5 to 5.5 Hz on the last sitting. The dose varied insignificantly for different symptoms The difference in pain relief was maintained after 4 weeks, even though the TENS sittings had stopped

27
DISCUSSION Till date no study has tried to assess effect of TENS in paediatric type 1 diabetes patients. The efficacy and efficiency of TENS as a therapeutic modality in children with diabetes and painful neuropathy is worthy of more extensive study.